Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Regeneron: It’s the Eylea Outlook That Matters
Barron's
Mon, 02/8/16 - 12:46 pm
Regeneron
Eylea
3 Things to Look for in Regeneron Pharmaceuticals Inc.'s Earnings
Motley Fool
Fri, 02/5/16 - 09:37 pm
Regeneron
earnings
How Amgen may Impact Regeneron Q4 Earnings
Bidness, ETC
Thu, 02/4/16 - 06:33 pm
Amgen
Regeneron
earnings
Will Regeneron’s Earnings Continue to Impress Investors?
Yahoo/Market Realist
Wed, 01/27/16 - 04:10 pm
earnings
Regeneron
Sanofi and Regeneron likely to cough up royalties to end Amgen's PCSK9 patent suit: Analyst
Fierce Pharma
Tue, 01/26/16 - 09:03 pm
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Repatha
Praluent
Will 2016 Be Regeneron Pharmaceuticals Inc.'s Best Year Yet?
Motley Fool
Wed, 01/6/16 - 03:11 pm
Regeneron
Praluent
Eylea
Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
Yahoo/TheStreet.com
Mon, 01/4/16 - 09:20 am
biotech
Sprout Pharmaceuticals
Addyi
Novartis
Entresto
Hillary Clinton
Regeneron
Biogen
CAR-T
Valeant Pharmaceuticals
gene therapy
Theranos
Incyte
Afrezza
What Does 2016 Hold for Biotech Stocks?
Motley Fool
Sun, 01/3/16 - 10:27 pm
biotech
Gilead Sciences
Celgene
Amgen
Regeneron
Sanofi
Biomarin
Sarepta Th
How Gilead Sciences M&A Can Pan Out Next Year
Bidness, ETC
Tue, 12/29/15 - 09:36 am
Gilead Sciences
M&A
Vertex Pharmaceuticals
Incyte
Biomarin
Regeneron
The Worst Regeneron Pharmaceuticals, Inc. Headlines in 2015
Motley Fool
Sat, 12/26/15 - 11:58 am
Regeneron
Amgen PCSK-9 Prescription Volumes Ahead of Regeneron Pharmaceuticals
Bidness, ETC
Fri, 12/18/15 - 09:09 am
Amgen
PCSK9 inhibitors
Regeneron
Sanofi
Repatha
Praluent
Latest cholesterol drug comes with a $14,600-a-year price tag
Marketwatch
Mon, 12/14/15 - 04:27 pm
cholesterol
Praluent
Regeneron
Sanofi
This May Be The Fastest-Growing Biotech Stock Next Year (Hint: It's Not Gilead Sciences)
Motley Fool
Mon, 12/14/15 - 10:07 am
Gilead Sciences
Regeneron
The new PCSK9 scorecard: Praluent favored by UnitedHealth, Repatha by CVS, both by Express Scripts
BioPharma Dive
Fri, 12/11/15 - 10:23 pm
PCSK9 inhibitors
Praluent
Repatha
Regeneron
Sanofi
Amgen
Unitedhealth Group
CVS
Express Scripts
Amgen and Regeneron Face Declining PCSK-9 Prescription Volumes
Bidness, ETC
Mon, 12/7/15 - 03:02 pm
Amgen
Regeneron
PCSK9 inhibitors
Sanofi
Praluent
Repatha
Repatha Vs. Praluent: Will Amgen's Patents Decide The Race For The Prevailing PCSK9 Inhibitor?
Seeking Alpha
Wed, 12/2/15 - 09:27 am
Repatha
Praluent
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
patents
UnitedHealth Unit Favors Sanofi, Regeneron Cholesterol Drug
Bloomberg
Tue, 12/1/15 - 10:16 am
Unitedhealth Group
Sanofi
Regeneron
Amgen
Praluent
Repatha
Sanofi, Regeneron prepped PCSK9 rollout with 'Cholesterol Counts' campaign
Fierce Pharma Marketing
Mon, 11/30/15 - 06:51 pm
Sanofi
Regeneron
PCSK9 inhibitors
Praluent
CVS Chooses Repatha as New Cholesterol Drug for Caremark
WSJ Online
Mon, 11/23/15 - 09:35 am
CVS Caremark
Amgen
Repatha
Sanofi
Regeneron
Praluent
Biotechs Go Low-Fat: Relevance To Amgen, Regeneron, The Medicines Company And Isis
Seeking Alpha
Thu, 11/19/15 - 04:39 pm
Amgen
Regeneron
Medicines Company
Isis Pharmaceuticals
Gilead Sciences
Biogen
Pages
« first
‹ previous
…
25
26
27
28
29
30
31
32
33
…
next ›
last »